Results 261 to 270 of about 1,385,287 (335)
Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease. [PDF]
PLoS OneLimerick E +8 more
europepmc +1 more source
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience. [PDF]
Ther Adv Musculoskelet DisGernert M +4 more
europepmc +1 more source
Correction to "Treatment of Recurrent IgA Nephropathy After Kidney Transplantation: Case Report and Comprehensive Literature Review". [PDF]
Clin Case Repeuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Introductory Immunology, 2014
The potential for stem cells to replace or restore tissues lost to injury or disease represents one of the most promising outcomes of regenerative medicine. However, immune rejection of stem cell grafts remains a challenge to clinical translation of stem
J. Actor
openaire +2 more sources
The potential for stem cells to replace or restore tissues lost to injury or disease represents one of the most promising outcomes of regenerative medicine. However, immune rejection of stem cell grafts remains a challenge to clinical translation of stem
J. Actor
openaire +2 more sources
Basic Transplantation Immunology
Surgical Clinics of North America, 2006Humans are protected from a daily onslaught of pathogenic organisms by an immune system that provides multiple layers of protection. Until solid organ transplantation became technically feasible in the early twentieth century, this constant state of surveillance for foreign cells that are associated with the immune response mostly was viewed as ...
D. Hale
openaire +3 more sources
Clinical transplantation immunology
Läkartidningen, 1985This chapter explores that immunology has become important in clinical transplantation. The problem with transplantations are not only surgical, but rather, or even primarily, immunological. The recipient of an incompatible transplant reacts immunologically and the transplant is rejected whether it consists of an organ or single cells.
E. Möller
openaire +3 more sources
Current Opinion in Nephrology and Hypertension, 1995
The success of transplantation is such that it is now the treatment of choice for many of those requiring renal replacement therapy. The use of other solid organs, including liver, pancreas, heart and lung, continues to progress. This article reviews some recent advances in our understanding of the immunological response to alloantigen and xenoantigen.
S T, Ball, M J, Dallman
openaire +2 more sources
The success of transplantation is such that it is now the treatment of choice for many of those requiring renal replacement therapy. The use of other solid organs, including liver, pancreas, heart and lung, continues to progress. This article reviews some recent advances in our understanding of the immunological response to alloantigen and xenoantigen.
S T, Ball, M J, Dallman
openaire +2 more sources
Surgical technology international, 2015
The replacement of diseased or damaged organs by transplantation became a reality in 1954, when a kidney was transplanted from one monozygotic twin to another. Barring technical difficulties, a graft between genetically identical (syngeneic) individuals is readily accepted and is termed an isograft.
Mihir M. Shah +2 more
+5 more sources
The replacement of diseased or damaged organs by transplantation became a reality in 1954, when a kidney was transplanted from one monozygotic twin to another. Barring technical difficulties, a graft between genetically identical (syngeneic) individuals is readily accepted and is termed an isograft.
Mihir M. Shah +2 more
+5 more sources